自身免疫性肝炎的研究进展
Research Advances in Autoimmune Hepatitis
DOI: 10.12677/ACM.2023.134744, PDF,   
作者: 李依琳:山东大学附属公共卫生临床中心,山东 济南
关键词: 自身免疫性肝炎发病机制诊断治疗Autoimmune Hepatitis Pathogenesis Diagnosis Therapy
摘要: 自身免疫性肝炎是一种病因不明的慢性进展性肝脏疾病,随着人们对该病的认识及诊疗水平的提高,其发病率呈上升趋势。自身免疫性肝炎以免疫球蛋白水平升高、自身免疫性抗体阳性、肝组织学界面性炎为主要特征,治疗上可选择一线治疗、替代治疗和肝脏移植等治疗方案,但都有一定局限性。本文就自身免疫性肝炎的流行特点、发病机制、诊断、治疗及预后相关研究进展做一综述。
Abstract: Autoimmune hepatitis is a chronic progressive liver disease of unknown etiology. With the im-provement of people’s understanding of the disease and the level of diagnosis and treatment, its in-cidence is on the rise. Autoimmune hepatitis is characterized by elevated immunoglobulin levels, positive autoimmune antibodies, and hepatic histological interface inflammation, and treatment options such as first-line therapy, replacement therapy, and liver transplantation are available, but all have limitations. This article reviews the research progress related to the epidemiological char-acteristics, pathogenesis, diagnosis, treatment and prognosis of autoimmune hepatitis.
文章引用:李依琳. 自身免疫性肝炎的研究进展[J]. 临床医学进展, 2023, 13(4): 5255-5261. https://doi.org/10.12677/ACM.2023.134744

参考文献

[1] (2018) Autoimmune Hepatitis. Nature Reviews Disease Primers, 4, Article Number: 18018. [Google Scholar] [CrossRef] [PubMed]
[2] Tanaka, A. (2020) Autoimmune Hepatitis: 2019 Update. Gut and Liver, 14, 430-438. [Google Scholar] [CrossRef] [PubMed]
[3] Zachou, K., Muratori, P., Koukoulis, G.K, et al. (2013) Review Article: Autoimmune Hepatitis—Current Management and Challenges. Alimentary Pharmacology & Therapeutics, 38, 887-913. [Google Scholar] [CrossRef] [PubMed]
[4] Lv, T., Li, M., Zeng, N., et al. (2019) Systematic Review and Me-ta-Analysis on the Incidence and Prevalence of Autoimmune Hepatitis in Asian, European, and American Population. Journal of Gastroenterology and Hepatology, 34, 1676-1684. [Google Scholar] [CrossRef] [PubMed]
[5] Primo, J., Merino, C., Fernandez, J., et al. (2004) Incidence and Prevalence of Autoimmune Hepatitis in the Area of the Hospital de Sagunto (Spain). Gastroenterology & Hepatology, 27, 239-243. [Google Scholar] [CrossRef
[6] Ngu, J.H., Bechly, K., Chapman, B.A., et al. (2010) Popula-tion-Based Epidemiology Study of Autoimmune Hepatitis: A Disease of Older Women? Journal of Gastroenterology and Hepatology, 25, 1681-1686. [Google Scholar] [CrossRef] [PubMed]
[7] Hurlburt, K.J., McMahon, B.J., Deubner, H., et al. (2002) Prevalence of Autoimmune Liver Disease in Alaska Natives. The American Journal of Gastroenterology, 97, 2402-2407. [Google Scholar] [CrossRef] [PubMed]
[8] Czaja, A.J. (2017) Global Disparities and Their Implica-tions in the Occurrence and Outcome of Autoimmune Hepatitis. Digestive Diseases and Sciences, 62, 2277-2292. [Google Scholar] [CrossRef] [PubMed]
[9] Gronbaek, L., Vilstrup, H., Pedersen, L., et al. (2018) Family Occurrence of Autoimmune Hepatitis: A Danish Nationwide Registry-Based Cohort Study. Journal of Hepatology, 69, 873-877. [Google Scholar] [CrossRef] [PubMed]
[10] Efe, C., Purnak, T. and Ozaslan, E. (2010) Concurrent Autoimmune Thyroid Diseases in Patients with Autoimmune Hepatitis. Journal of Clinical Gastroenterology, 44, 660-661. [Google Scholar] [CrossRef
[11] Umemura, T., Katsuyama, Y., Yoshizawa, K., et al. (2014) Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Au-toimmune Hepatitis in Japan. PLOS ONE, 9, e100565. [Google Scholar] [CrossRef] [PubMed]
[12] Lim, Y.S., Oh, H.B., Choi, S.E., et al. (2008) Susceptibility to Type 1 Autoimmune Hepatitis Is Associated with Shared Amino Acid Sequences at Positions 70-74 of the HLA-DRB1 Molecule. Journal of Hepatology, 48, 133-139. [Google Scholar] [CrossRef] [PubMed]
[13] Duarte-Rey, C., Pardo, A.L., Rodríguez-Velosa, Y., et al. (2009) HLA Class II Association with Autoimmune Hepatitis in Latin America: A Meta-Analysis. Autoimmunity Reviews, 8, 325-331. [Google Scholar] [CrossRef] [PubMed]
[14] Hiraide, A., Imazeki, F., Yokosuka, O., et al. (2005) Fas Poly-morphisms Influence Susceptibility to Autoimmune Hepatitis. The American Journal of Gastroenterology, 100, 1322-1329. [Google Scholar] [CrossRef] [PubMed]
[15] Umemura, T., Joshita, S., Yamazaki, T., et al. (2016) Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan. Scientific Reports, 6, Article No. 29770. [Google Scholar] [CrossRef] [PubMed]
[16] Fan, L., Tu, X., Zhu, Y., et al. (2005) Genetic Association of Vitamin D Receptor Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cirrhosis in the Chinese. Journal of Gastro-enterology and Hepatology, 20, 249-255. [Google Scholar] [CrossRef] [PubMed]
[17] Czaja, A.J. (2015) Transitioning from Idiopathic to Ex-plainable Autoimmune Hepatitis. Digestive Diseases and Sciences, 60, 2881-2900. [Google Scholar] [CrossRef] [PubMed]
[18] Christen, U. and Hintermann, E. (2014) Pathogen Infection as a Possible Cause for Autoimmune Hepatitis. International Reviews of Immunology, 33, 296-313. [Google Scholar] [CrossRef] [PubMed]
[19] Efe, C., Kav, T., Aydin, C., et al. (2014) Low Serum Vitamin D Levels Are Associated with Severe Histological Features and Poor Response to Therapy in Patients with Autoimmune Hepatitis. Digestive Diseases and Sciences, 59, 3035-3042. [Google Scholar] [CrossRef] [PubMed]
[20] Albert, L.J. and Inman, R.D. (1999) Molecular Mimicry and Autoimmunity. The New England Journal of Medicine, 341, 2068-2074. [Google Scholar] [CrossRef
[21] Manns, M.P., Czaja, A.J., Gorham, J.D., et al. (2010) Diagnosis and Management of Autoimmune Hepatitis. Hepatology, 51, 2193-2213. [Google Scholar] [CrossRef] [PubMed]
[22] Liberal, R., Grant, C.R., Mieli-Vergani, G., et al. (2013) Autoimmune Hep-atitis: A Comprehensive Review. Journal of Autoimmunity, 41, 126-139. [Google Scholar] [CrossRef] [PubMed]
[23] Krawitt, E.L. (2006) Autoimmune Hepatitis. The New England Journal of Medicine, 354, 54-66. [Google Scholar] [CrossRef
[24] Johnson, P.J. and McFarlane, I.G. (1993) Meeting Report: Interna-tional Autoimmune Hepatitis Group. Hepatology, 18, 998-1005. [Google Scholar] [CrossRef] [PubMed]
[25] Zachou, K., Gatselis, N., Papadamou, G., et al. (2011) Mycopheno-late for the Treatment of Autoimmune Hepatitis: Prospective Assessment of Its Efficacy and Safety for Induction and Maintenance of Remission in a Large Cohort of Treatment-Naïve Patients. Journal of Hepatology, 55, 636-646. [Google Scholar] [CrossRef] [PubMed]
[26] Alvarez, F., Berg, P.A., Bianchi, F.B., et al. (1999) International Autoimmune Hepatitis Group Report: Review of Criteria for Diagnosis of Autoimmune Hepatitis. Journal of Hepatology, 31, 929-938. [Google Scholar] [CrossRef
[27] Gleeson, D., Heneghan, M.A. and British Society of Gas-troenterology (2011) British Society of Gastroenterology (BSG) Guidelines for Management of Autoimmune Hepatitis. Gut, 60, 1611-1629. [Google Scholar] [CrossRef] [PubMed]
[28] Al-Chalabi, T., Boccato, S., Portmann, B.C., et al. (2006) Autoim-mune Hepatitis (AIH) in the Elderly: A Systematic Retrospective Analysis of a Large Group of Consecutive Patients with Definite AIH Followed at a Tertiary Referral Centre. Journal of Hepatology, 45, 575-583. [Google Scholar] [CrossRef] [PubMed]
[29] Wang, Q.X., Jiang, W.J., Miao, Q., et al. (2013) Clinical and His-tological Features of Autoantibody-Negative Autoimmune Hepatitis in Chinese Patients: A Single Center Experience. Journal of Digestive Diseases, 14, 175-180. [Google Scholar] [CrossRef] [PubMed]
[30] Wang, G., Tanaka, A., Zhao, H., et al. (2021) The Asian Pacific Association for the Study of the Liver Clinical Practice Guidance: The Diagnosis and Management of Patients with Au-toimmune Hepatitis. Hepatology International, 15, 223-257. [Google Scholar] [CrossRef] [PubMed]
[31] Vergani, D., Alvarez, F., Bianchi, F.B., et al. (2004) Liver Au-toimmune Serology: A Consensus Statement from the Committee for Autoimmune Serology of the International Auto-immune Hepatitis Group. Journal of Hepatology, 41, 677-683. [Google Scholar] [CrossRef] [PubMed]
[32] Ma, Y., Okamoto, M., Thomas, M.G., et al. (2002) Antibodies to Conformational Epitopes of Soluble Liver Antigen Define a Severe Form of Autoimmune Liver Disease. Hepatology, 35, 658-664. [Google Scholar] [CrossRef] [PubMed]
[33] Hennes, E.M., Zeniya, M., Czaja, A.J., et al. (2008) Simplified Crite-ria for the Diagnosis of Autoimmune Hepatitis. Hepatology, 48, 169-176. [Google Scholar] [CrossRef] [PubMed]
[34] Balitzer, D., Shafizadeh, N., Peters, M.G., et al. (2017) Autoimmune Hepa-titis: Review of Histologic Features Included in the Simplified Criteria Proposed by the International Autoimmune Hepa-titis Group and Proposal for New Histologic Criteria. Modern Pathology, 30, 773-783. [Google Scholar] [CrossRef] [PubMed]
[35] Beer, A. and Dienes, H.P. (2021) Autoimmune Hepatitis—Is Histology Conclusive? Annals of Translational Medicine, 9, 733. [Google Scholar] [CrossRef] [PubMed]
[36] Czaja, A.J. (2008) Performance Parameters of the Diagnostic Scoring Systems for Autoimmune Hepatitis. Hepatology, 48, 1540-1548. [Google Scholar] [CrossRef] [PubMed]
[37] Qiu, D., Wang, Q., Wang, H., et al. (2011) Validation of the Simplified Criteria for Diagnosis of Autoimmune Hepatitis in Chinese Patients. Journal of Hepatology, 54, 340-347. [Google Scholar] [CrossRef] [PubMed]
[38] Gatselis, N.K., Zachou, K., Papamichalis, P., et al. (2010) Compar-ison of Simplified Score with the Revised Original Score for the Diagnosis of Autoimmune Hepatitis: A New or a Com-plementary Diagnostic Score? Digestive and Liver Disease, 42, 807-812. [Google Scholar] [CrossRef] [PubMed]
[39] 马雄, 王绮夏, 肖潇, 等. 自身免疫性肝炎诊断和治疗指南(2021) [J]. 临床肝胆病杂志, 2022, 38(1): 42-49.
[40] Czaja, A.J. (2016) Diagnosis and Management of Autoimmune Hepatitis: Current Status and Future Directions. Gut and Liver, 10, 177-203. [Google Scholar] [CrossRef] [PubMed]
[41] Czaja, A.J. (2002) Treatment Strategies in Autoimmune Hepatitis. Clinical Liver Disease, 6, 799-824. [Google Scholar] [CrossRef
[42] Manns, M.P., Woynarowski, M., Kreisel, W., et al. (2010) Budesonide Induces Remission More Effectively than Prednisone in a Controlled Trial of Patients with Autoimmune Hepatitis. Gastroenterology, 139, 1198-1206. [Google Scholar] [CrossRef] [PubMed]
[43] Nicoll, A.J., Roberts, S.K., Lim, R., et al. (2019) Beneficial Re-sponse to Mycophenolate Mofetil by Patients with Autoimmune Hepatitis Who Have Failed Standard Therapy, Is Pre-dicted by Older Age and Lower Immunoglobulin G and INR Levels. Alimentary Pharmacology & Therapeutics, 49, 1314-1322. [Google Scholar] [CrossRef] [PubMed]
[44] Futagawa, Y. and Terasaki, P.I. (2004) An Analysis of the OPTN/UNOS Liver Transplant Registry. Clinical Transplants, 354, 315.